Skip to main content
. 2014 Jun 20;10(8):2471–2481. doi: 10.4161/hv.29571

graphic file with name khvi-10-08-10929571-g002.jpg

Figure 2. Percentage (95%CI) of subjects who achieved seroresponse 1 mo after immunization with MenACWY-CRM197. Seroresponse was defined as the percentage of subjects with post-vaccination hSBA ≥ 1:8 in subjects with a pre-vaccination hSBA < 1:4, and at least a 4-fold increase in post-vaccination hSBA in subjects with pre-vaccination hSBA ≥ 1:4.